HGH 191AA (Somatropin）H40 40iu*10vials

HGH 191AA (Growth Hormone) H40 40iu*10 vials is the next-generation flagship product in the H-series recombinant human growth hormone research product portfolio. It represents the highest level of supersaturated, ultimate iteration, a comprehensive upgrade based on the classic H36 flagship specification and all lower gradient versions (including H8, H10, H12, H15, and H24). Utilizing a standard 191-amino acid full-length human natural homologous sequence, its molecular structure is 100% identical to natural pituitary-secreted human growth hormone, exhibiting zero structural defects, zero mutations, ultra-high receptor compatibility, and complete preservation of natural biological activity. Employing upgraded industrial-grade ultra-fine multi-stage purification and full-vacuum deep-lock freeze-drying technology, H40 40iu achieves unprecedented supersaturated specific activity, completely breaking through the efficacy ceiling of the H36 version. As the highest concentration and largest-load exogenous direct growth hormone supplement research material in the entire H-series matrix, it completely overcomes the limitations of endogenous pituitary secretion, achieving an ultra-high amplitude, zero-attenuation, and strictly linear extreme endocrine axis superactivation effect. Specifically designed for world-class research on ultra-extreme anabolic mechanisms and ultra-interventional modeling of reversing refractory systemic metabolic disorders, this product serves as the ultimate core authoritative reference material for ultra-high threshold extreme growth hormone pharmacology, thorough intervention of refractory severe metabolic disorders, and cutting-edge preclinical physiological research.

Product Function Research Value

In world-class ultra-extreme systems laboratory research, HGH 191AA H40 fully supersaturates the downstream JAK2/STAT5 signaling cascade of GH/IGF-1, triggering extreme peak somatic cell proliferation, ultimate proliferation of ultra-maximum density lean muscle fibers, complete breakdown of stubborn visceral and subcutaneous lamellar fat, and a comprehensive burst of ultimate basal metabolism. Its superior overall phenotypic performance surpasses and dominates all conventional graded products, including H36, H24, H15, H12, H10, and H8. It sets a new industry-leading benchmark for extreme efficacy in core research dimensions: extreme lean muscle hypertrophy under extreme conditions and radical cure of large-scale severe trauma, complete eradication of lifelong stubborn layered fat accumulation, maximizing the overall basal metabolic rate, comprehensively and thoroughly inhibiting deep cellular aging throughout the body, and extremely precise regulation of somatic cell growth under extreme conditions. Unlike endogenous GHRH secretory peptides limited by thresholds and all low-specification H-series products with limited intervention, H40 40iu ultra-high-dose exogenous supplementation achieves unrestricted, unlimited linear peak growth hormone supplementation. It completely eliminates individual endogenous response bias, long-term signal attenuation, and efficacy fluctuations, maintaining ultra-zero bias and ultra-stable saturated experimental phenotypic output even under continuous extreme intervention throughout the year. As the absolute top-level ultimate specification of the newly upgraded H-series matrix, H40 perfectly balances extreme peak efficacy and extreme scientific research safety and tolerability. It is uniquely suitable for ultimate screening at ultra-high dose thresholds, super-modeling of extreme metabolic remodeling throughout the entire cycle and under full load, in-depth exploration of mechanisms for extreme optimization of whole-body components, and verification of extreme solutions for ultra-high quality complex peptide combinations. It provides authoritative new benchmark experimental data with full saturation, maximum amplitude, ultra-high discrimination, and zero error reproducibility for advanced growth hormone pharmacology, radical intervention for severe refractory metabolic syndrome, and comprehensive advanced anti-aging physiological research.

Core Product Advantages

1. 191AA All-Natural Homologous Zero-Defect Peak Activity Structure: Standard, complete, full-length natural human growth hormone sequence, without mutations, truncation, structural defects, or immunogenicity bias. The molecular conformation is completely homologous to natural human growth hormone, possessing extremely high receptor binding efficiency and perfect physiological simulation realism, comprehensively superior to all modified, fragmented, and conventional gradient growth hormone peptide products in core biological performance.

2. 40iu Next-Generation H-Series Ultra-High Specificity